Investors in fantasy sports betting company DraftKings (NASDAQ:DKNG) have started 2022 on a down note. DKNG stock has already declined more than 20% since the start of January, adding to its substantial losses in 2021. By comparison, the S&P 500 index has only dipped 4.7% in January. Source: Postmodern Studio / Shutterstock.com DKNG stock hit
Stocks to buy
The Sofi Technologies (NASDAQ:SOFI) pullback, which started in November, has carried on into the new year. Since the start of 2022, SOFI stock has taken another 5% plunge, changing hands now for around $15 per share. Source: rafapress / Shutterstock.com What has caused this continued decline for the fintech play? The prospect of higher interest rates
Novavax (NASDAQ:NVAX) stock has been an under-performer among stocks that have been in the Covid-19 vaccine race. After touching highs of $331.7 in February 2021, NVAX stock has plunged to its current price levels of $90. Source: Vladimka production / Shutterstock.com Of course, there have been fundamental factors that have served as catalysts for the
In recent days, multiple analysts on Wall Street have been defending Rivian (NASDAQ:RIVN) stock, and I’ve become convinced that the worries about the company’s production shortfall are overblown. Moreover, I’ve recently become more optimistic about the longer-term macro outlook for high-quality growth stocks in general. Source: Michael Vi / Shutterstock As a result of these
Palantir (NYSE:PLTR) stock took a beating last year. PLTR stock is down more than 67% from its 52-week high price, currently sitting at $14.56. The signs of deceleration in the company’s public-sector business have been a key reason for the sluggishness. However, the positive developments in the past few months reiterate my belief in the
AT&T (NYSE:T) had a difficult fiscal year from an investor perspective. In 2021, the company could not live up to its expectations. However, investors need only look forward as they offer a bright future for those who invest in T stock now. AT&T’s 5G ambitions may align with its roots. But it will take time
I am bullish on Chinese electric vehicle (EV) maker Nio (NYSE:NIO). That’s a tough stance to take right now. Beijing is stepping up regulatory pressure on domestic companies. Nio stock is just one among several high-profile casualties of these moves. However, the underlying fundamentals of the company remain solid. Source: Sundry Photography / Shutterstock.com In
Plug Power (NASDAQ:PLUG) is continuing to take steps that further extend its first-mover advantage in multiple aspects of the hydrogen ecosystem. Meanwhile, multiple governments are looking to implement new programs that will promote the use of hydrogen. As a result of these developments, I remain very bullish on PLUG stock. Source: Shutterstock Also making the
Over the past few years, I’ve been a big fan of Roku (NASDAQ:ROKU). I’ve written positively about ROKU stock during its good times in the second half of 2020 and early 2021, its bad times at the beginning of the coronavirus pandemic and in the second half of 2021, and its mediocre times in early
Dissimilar to any disruptive event in modern American history, the coronavirus pandemic is the first disaster that has affected everyone: across state borders, class and income spectrums and demographic categories. Even if you weren’t especially negatively impacted, you almost certainly noticed the disruption to your working environment. Many were able to operate remotely while others
Wall Street investors are very fickle these days. They are showing no commitment in either direction for longer than a few hours at a time. This makes it very difficult to commit capital with great conviction. This dynamic is part of what has impacted Teladoc (NYSE:TDOC) stock. TDOC has given up the entire relief rally
Investors in Robinhood Markets (NASDAQ:HOOD) stock have not had much to celebrate since the company went public in July 2021. In fact, shares are down nearly 60% over the past six months. Yet, most market participants pay more attention to what users of the Robinhood app buy and sell more than price swings in HOOD
Amazon (NASDAQ:AMZN) stock has been in a sort of free fall for the past several months. I suspect that it may be at a point where investors can begin accumulating it. One reason is that I foresee that AMZN stock will stage a rebound sometime this quarter or in the spring. Source: BigTunaOnline / Shutterstock.com
Chinese premium electric vehicle (EV) maker Nio (NYSE:NIO) hasn’t had a smooth 2021. NIO stock was once trading at the highs of $60 and is down to $30 today. Nothing has gone wrong with the company but the overall investor sentiment has led to the sell-off. There are also several concerns associated with Chinese regulations and
Novavax (NASDAQ:NVAX), the Gaithersburg, Maryland-based biotech company, still has not submitted its Covid-19 vaccine for emergency use approval (EUA) to the Food and Drug Administration (FDA). The company says it will do so by the end of January. But the market is skeptical and is still waiting to see when the EUA will happen. As
I’ve had my eye on Nio (NYSE:NIO) for a while now. I first bought NIO stock in June 2020 when it was less than $8 per share. I sold a little more than a year later when it was close to $50. Source: xiaorui / Shutterstock.com Sure, Nio was already off its all-time high at
Growth stocks remain the best-performing equities of the past decade by a wide margin. These stocks have outperformed via providing revenue and earnings growth higher than the market average at a time when interest rates remain depressed. However, many top growth stocks had a mixed year in 2021. And 2022 is shaping up to be
Upstart Holdings (NASDAQ:UPST) was one of the big investment growth stories of 2021. At least, until last October. At that point, UPST stock crashed and it also became a cautionary tale about the downside of meme stocks. Upstart shares are now trading at around $120, which is right about where they were last June. They’re
The Covid-19 pandemic has worked in the favor of pharmaceutical companies. Many have become hot picks today. Although Novavax (NASDAQ:NVAX) hasn’t had a smooth ride lately, there is a lot to look forward to. Investors tend to think that the current surge in Covid-19 cases across the globe could mean an end of the pandemic shortly
Recently a number of reports emerged, including a Jan. 5 article in Barron’s magazine, that Charlie Munger has “doubled down” into shares of Alibaba Group Holding (NYSE:BABA). In the past, I have written why BABA stock looks cheap. But I wanted to write about why he might see Alibaba as a worthwhile investment to buy
- « Previous Page
- 1
- …
- 69
- 70
- 71
- 72
- 73
- …
- 91
- Next Page »